Cargando…
Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
Migraine is a common, polygenic disorder that is characterized by moderate to severe headache attacks. Migraine attacks are commonly treated with triptans, i.e. serotonin receptor agonists. However, triptans are effective in ~ 60% of the population, and the mechanisms of triptans are debated. Here,...
Autores principales: | Kogelman, Lisette J. A., Falkenberg, Katrine, Ottosson, Filip, Ernst, Madeleine, Russo, Francesco, Stentoft-Hansen, Valdemar, Demharter, Samuel, Tfelt-Hansen, Peer, Cohen, Arieh S., Olesen, Jes, Hansen, Thomas Folkmann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390468/ https://www.ncbi.nlm.nih.gov/pubmed/37524744 http://dx.doi.org/10.1038/s41598-023-38904-1 |
Ejemplares similares
-
Multi-omics to predict changes during cold pressor test
por: Kogelman, Lisette J. A., et al.
Publicado: (2022) -
Success and failure of triptans
por: Saxena, Pramod R., et al.
Publicado: (2001) -
Changes in the gene expression profile during spontaneous migraine attacks
por: Kogelman, Lisette J. A., et al.
Publicado: (2021) -
The 5-HT(1F) receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials
por: Tfelt-Hansen, Peer C., et al.
Publicado: (2012) -
Predicting treatment response using pharmacy register in migraine
por: Hansen, Thomas Folkmann, et al.
Publicado: (2019)